Clinical Trials for Waldenström's Macroglobulinemia (WM)

Find clinical trials for waldenström's macroglobulinemia (wm). Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

NCT ID: NCT06441214

This clinical trial is studying how patients with Waldenström's Macroglobulinemia (WM), a type of blood cancer, are treated in Italy. Specifically, it looks at patients who received a medication ca...

Recruiting

Type: observational Locations: Palermo, , Italy, Ravenna, , Italy +26 more

Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia

NCT ID: NCT06942507

This clinical trial is studying a new combination treatment for patients with Waldenström macroglobulinemia (WM), a type of blood cancer. The treatment combines three medications: zanubrutinib, bor...

Not yet recruiting

Phase: NA Type: interventional Locations: Beijing, Beijing, China

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

NCT ID: NCT06043011

The RUBIN trial is focused on collecting important information about various blood cancers, including Chronic Lymphocytic Leukemia (CLL) and several types of lymphoma. The goal is to create a natio...

Recruiting

Type: observational Locations: Freiburg, , Germany

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions